Tissue Regenix Group Stock Forecast for 2023 - 2025 - 2030
Updated on 05/04/2024
Tissue Regenix Group Stock Forecast and Price Target
If Tissue Regenix Group's stock price reached the average yearlong target of £1.20 given by well-known analysts in recent months, there would be a potential upside of approximately 93.55% from its last closing price in May, 2024. This potential increase is based on a high estimate of £1.20 and a low estimate of £1.20. If you are not interested in TRX stock, you may still be interested in its competitors and their current standings.
93.55% Upside
Tissue Regenix Group Fair Value Forecast for 2023 - 2025 - 2030
In the last four years, Tissue Regenix Group's Price has grown by 100.00%, rising from £0.00 to £0.00. For the next year, analysts predict that Fair Value will reach £0.66 – an increase of 100.00%. Over the next seven years, experts believe that Tissue Regenix Group's Fair Value will grow at a rate of 100.00%.
Tissue Regenix Group Revenue Forecast for 2023 - 2025 - 2030
In the last two years, Tissue Regenix Group's Revenue has grown by 90.80%, rising from £12.83M to £24.48M. For the next year, 0 analysts project Tissue Regenix Group's Revenue to drop by 24.56%, reaching £18.47M. By 2030, professionals believe that Tissue Regenix Group's Revenue will decrease by 21.23%, reaching £19.28M – a concerning trend for the company.
.jpg)
Tissue Regenix Group EBITDA Forecast for 2023 - 2025 - 2030
In the last two years, Tissue Regenix Group's EBITDA has seen a drop from £-3.47M to £-1.04M – a 70.03% decrease. According to 2 major analysts, Tissue Regenix Group's EBITDA will fall by 275.00% in the next year, reaching £1.82M. Professionals believe that By 2030, Tissue Regenix Group's EBITDA will fall to £2.81M– a 370.34% decrease from its current value.
Tissue Regenix Group EBIT Forecast for 2023 - 2025 - 2030
In the last two years, Tissue Regenix Group's EBIT has gone down from £-4.17M to £-2.01M – a 51.80% drop. In the next year, 2 analysts estimate that Tissue Regenix Group's EBIT will decrease by 153.23%, reaching £1.07M. According to professional forecasts, in 2030, Tissue Regenix Group's EBIT will decrease by 152.33%, reaching £1.05M.
Tissue Regenix Group EPS Price Prediction Forecast for 2023 - 2025 - 2030
In the last four years, Tissue Regenix Group's EPS has grown by 100.00%, rising from £-0.08 to £0.00. For the next year, analysts predict that EPS will reach £0.01 – an increase of 100.00%. Over the next seven years, experts believe that Tissue Regenix Group's EPS will grow at a rate of 100.00%.
.jpg)